Literature DB >> 15987820

Role of FOXO1A in the regulation of insulin-like growth factor-binding protein-1 in human endometrial cells: interaction with progesterone receptor.

J J Kim1, O L Buzzio, S Li, Z Lu.   

Abstract

Insulin-like growth factor-binding protein-1 (IGFBP1) is a major secretory product of the decidualized endometrium. In the present study, we investigated the role of two transcription factors, progesterone receptor (PGR) and a member of the forkhead box class O family of transcription factors (FOXO1A), in the regulation of the IGFBP1 gene in endometrial cells. Human endometrial fibroblasts (HuF) expressed FOXO1A, progesterone receptor A (PGRA), and progesterone receptor B (PGRB) proteins, whereas the endometrial adenocarcinoma cell line, HEC-1B cells, expressed only FOXO1A and no detectable PGR proteins. When FOXO1A expression was silenced using small interference RNA, IGFBP1 expression decreased in both HuF and HEC-1B cells. Using the chromatin immunoprecipitation technique, we demonstrated that liganded PGR was recruited to the IGFBP1 promoter region (-358 to -49). In addition, immunoprecipitation of HuF nuclear proteins with a PGR antibody followed by immunoblotting with anti-FOXO1A revealed that these two proteins interact in these cells. Reporter studies demonstrated that whereas liganded PGRA or PGRB increased a progesterone response element-linked reporter construct, pPRE/ GRE.E1b.Luc, coexpression of FOXO1A inhibited the PGRB response in HuF and synergistically increased PGRA and PGRB response in HEC-1B cells. Furthermore, in HEC-1B cells, FOXO1A increased IGFBP1 promoter activity, and coexpression of PGRA or PGRB further increased the promoter activity in a cooperative manner. In HuF, the response to FOXO1A and PGR was not additive; in fact, it was lower than the sum of the individual responses. Thus, FOXO1A and PGR associate with one another, and each influences the transactivating potential of the other. The cell type-dependent responses strongly implicate the involvement of other cofactors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15987820      PMCID: PMC1237025          DOI: 10.1095/biolreprod.105.043182

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  36 in total

1.  Activation of the protein kinase A pathway in human endometrial stromal cells reveals sequential categorical gene regulation.

Authors:  Emily P Tierney; Suzana Tulac; Se-Te Joseph Huang; Linda C Giudice
Journal:  Physiol Genomics       Date:  2003-12-16       Impact factor: 3.107

2.  Phosphotryptic peptide analysis of human progesterone receptor. New phosphorylated sites formed in nuclei after hormone treatment.

Authors:  P L Sheridan; R M Evans; K B Horwitz
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

3.  Effect of progestin, antiprogestin, and relaxin on the accumulation of prolactin and insulin-like growth factor-binding protein-1 messenger ribonucleic acid in human endometrial stromal cells.

Authors:  L Tseng; J G Gao; R Chen; H H Zhu; J Mazella; D R Powell
Journal:  Biol Reprod       Date:  1992-09       Impact factor: 4.285

4.  11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1.

Authors:  Michael Potente; Beate Fisslthaler; Rudi Busse; Ingrid Fleming
Journal:  J Biol Chem       Date:  2003-05-28       Impact factor: 5.157

Review 5.  Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair.

Authors:  B Gellersen; J Brosens
Journal:  J Endocrinol       Date:  2003-09       Impact factor: 4.286

6.  Functional analysis of glucocorticoid and insulin response sequences in the rat insulin-like growth factor-binding protein-1 promoter.

Authors:  R Goswami; R Lacson; E Yang; R Sam; T Unterman
Journal:  Endocrinology       Date:  1994-02       Impact factor: 4.736

7.  Regulation of insulin-like growth factor binding protein-1 promoter activity by FKHR and HOXA10 in primate endometrial cells.

Authors:  J Julie Kim; Hugh S Taylor; G Eda Akbas; Isabelle Foucher; Alain Trembleau; Randal C Jaffe; Asgerally T Fazleabas; Terry G Unterman
Journal:  Biol Reprod       Date:  2003-01       Impact factor: 4.285

Review 8.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

9.  Hoxa5 overexpression correlates with IGFBP1 upregulation and postnatal dwarfism: evidence for an interaction between Hoxa5 and Forkhead box transcription factors.

Authors:  Isabelle Foucher; Michel Volovitch; Monique Frain; J Julie Kim; Jean-Claude Souberbielle; Lixia Gan; Terry G Unterman; Alain Prochiantz; Alain Trembleau
Journal:  Development       Date:  2002-09       Impact factor: 6.868

10.  Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B.

Authors:  P Kastner; A Krust; B Turcotte; U Stropp; L Tora; H Gronemeyer; P Chambon
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

View more
  49 in total

1.  Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.

Authors:  Xunqin Yin; Mary Ellen Pavone; Zhenxiao Lu; JianJun Wei; J Julie Kim
Journal:  J Clin Endocrinol Metab       Date:  2011-11-09       Impact factor: 5.958

Review 2.  Progesterone receptors, their isoforms and progesterone regulated transcription.

Authors:  Britta M Jacobsen; Kathryn B Horwitz
Journal:  Mol Cell Endocrinol       Date:  2011-09-17       Impact factor: 4.102

3.  Expression of FOXO1 is associated with GATA3 and Annexin-1 and predicts disease-free survival in breast cancer.

Authors:  Yanyuan Wu; Yayha Elshimali; Marianna Sarkissyan; Hezla Mohamed; Sheila Clayton; Jaydutt V Vadgama
Journal:  Am J Cancer Res       Date:  2011-11-21       Impact factor: 6.166

4.  GnRH antagonists may affect endometrial receptivity.

Authors:  Beth W Rackow; Harvey J Kliman; Hugh S Taylor
Journal:  Fertil Steril       Date:  2008-04-14       Impact factor: 7.329

Review 5.  Progesterone action in breast, uterine, and ovarian cancers.

Authors:  Caroline H Diep; Andrea R Daniel; Laura J Mauro; Todd P Knutson; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2015-01-13       Impact factor: 5.098

Review 6.  The role of FOXO1 in the decidual transformation of the endometrium and early pregnancy.

Authors:  Takeshi Kajihara; Jan J Brosens; Osamu Ishihara
Journal:  Med Mol Morphol       Date:  2013-02-05       Impact factor: 2.309

7.  Genome-wide analysis of histone modifications in human endometrial stromal cells.

Authors:  Isao Tamura; Yasuyuki Ohkawa; Tetsuya Sato; Mikita Suyama; Kosuke Jozaki; Maki Okada; Lifa Lee; Ryo Maekawa; Hiromi Asada; Shun Sato; Yoshiaki Yamagata; Hiroshi Tamura; Norihiro Sugino
Journal:  Mol Endocrinol       Date:  2014-07-29

8.  FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization.

Authors:  Yasmin M Vasquez; Erik C Mazur; Xilong Li; Ramakrishna Kommagani; Lichun Jiang; Rui Chen; Rainer B Lanz; Ertug Kovanci; William E Gibbons; Francesco J DeMayo
Journal:  Mol Endocrinol       Date:  2015-01-13

9.  Regulation of human endometrial stromal proliferation and differentiation by C/EBPβ involves cyclin E-cdk2 and STAT3.

Authors:  Wei Wang; Robert N Taylor; Indrani C Bagchi; Milan K Bagchi
Journal:  Mol Endocrinol       Date:  2012-10-24

10.  Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.

Authors:  Caroline H Diep; Todd P Knutson; Carol A Lange
Journal:  Mol Cancer Res       Date:  2015-11-17       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.